Configure, sample and produce your supplement range in one place.
At a glance
- Format suitability
- Reviewed for gummies and powder sticks — confirmed per project.
Why brands use it
Why brands use Reishi Extract
Reishi Extract is a botanical extract reviewed against the target market’s botanical rules, sitting in the botanicals family. On DAT Supply briefs the positioning is set by the brand brief and reviewed against the target market’s claim rules — we do not pre-position an active for any single benefit. Editorial framing uses only EU 432/2012- or DSHEA-compatible wording — we never promote unauthorised claims, even when the active has consumer-side momentum. Format-wise we have considered Reishi Extract for gummies and powder stick; the per-format formulation notes below describe the live constraints (taste, payload, stability, packaging) we tune in the formulation pass. Sourcing form (extract ratio for botanicals, salt or chelate form for minerals, free-form vs ester for amino acids) is reviewed against the brief, with documentation matched to the target market’s import rules. Inclusion rate and claim wording are reviewed per project — we don’t publish off-the-shelf doses.
FormulationHow we use Reishi Extract in formulas
A public-safe formulation reference — how this active behaves in our
formats, common pairings and handling notes. Final formulation, dose and
on-pack copy are confirmed per project.
- Heat stable
- Limited — use coated forms
- Soluble in matrix
- Conditional
- Vegan supply
- Project-specific
Claim wordingEU-authorised health claims
EU-authorised wording for this ingredient is reviewed per project against Reg. 1924/2006 and the authorised list under Reg. 432/2012. No final claim wording is implied by this page.
Botanical actives like Reishi Extract sit in a partially-harmonised EU claims position: most botanical health claims remain on hold (the "on-hold list"), and country-level rules (Italy, France, Spain, Belgium) layer on top with their own positive and negative lists for botanical use. Novel-food status is checked before any brief moves forward, alongside any traditional-use route where it applies. UK rules track EU wording post-Brexit but the GB market follows its own retained list. For the US market, structure-function wording under DSHEA applies, with the FDA disclosure on pack. Pack copy is rewritten per market and reviewed per project.
EU-authorised health claims Authorised at ≥15% NRV per daily serving. Claim wording must appear verbatim on consumer packaging. DAT reviews final pack copy per project against EU 1924/2006 and the authorised list under EU 432/2012.
Serving
Typical serving and reference level
Where the serving level for Reishi Extract is set, and who sets it. The
figure that reaches your label is fixed against the specification for your
formula and your market — not read off this page.
- Measured in
- mg
Reference level Typical anchor: mg per serving — confirmed per project.
Reishi Extract is measured by weight (mg) per serving on DAT Supply briefs. The working anchor — the inclusion rate against which target-market claim wording is reviewed — is set during the formulation pass for each project rather than published as a fixed number on the public page. Final per-serving load depends on the chosen format (gummy payload window, capsule fill weight, softgel oil load, sachet or powder scoop size, oral-liquid bottle geometry) and the claim wording the brand needs to support against the target market. Sourcing form (extract ratio, standardised marker, micronised vs granular, salt or chelate form) is reviewed in the same pass. Country-level upper limits (France, Italy, Belgium for the EU; California Prop 65 for the US) are checked before any inclusion rate is finalised. Dose is confirmed per project — we don’t publish off-the-shelf dose tables for any active in the catalogue.
Research library
The evidence behind Reishi Extract
8 studies relevant to Reishi Extract, strongest
evidence first. Peer-reviewed sources and regulatory opinions. Citations only — DAT cites
the science, it does not endorse the publishers. Studies are on the ingredient, not on any
finished product.
Reishi ExtractPeer-reviewed studyModerate evidence
Effects of Ganoderma lucidum on stress and sleep: a randomized controlled trial
- Population
- Healthy adults with mild stress
- Studied dose
- 1.5 g/day
- Duration
- 8 weeks
RCT in 132 healthy adults found reishi extract (1.5 g/day) reduced fatigue and improved sleep quality after 8 weeks.
Reishi ExtractPeer-reviewed studyModerate evidence
Effects of Reishi on sleep quality and fatigue
- Population
- Adults with neurasthenia
- Studied dose
- 1.5 g/day
- Duration
- 8 weeks
RCT in 132 adults with neurasthenia found reishi extract (1.5 g/day) improved fatigue and well-being after 8 weeks.
Reishi ExtractPeer-reviewed studyModerate evidence
Ganoderma lucidum (Reishi) for cancer treatment
- Population
- Cancer patients (various types)
- Studied dose
- 1.5-5.4 g/day of reishi extract
- Duration
- 4-12 weeks
Cochrane review of 5 RCTs found reishi increased immune cell counts (CD3+, CD4+, NK cells) in cancer patients, but evidence for tumor response was insufficient.
Reishi ExtractPeer-reviewed study
Antioxidant and anti-inflammatory effects of Ganoderma lucidum
- Population
- In vitro and animal models
- Studied dose
- Not applicable
- Duration
- Not applicable
In vitro and animal study showing polysaccharide and triterpene fractions reduce oxidative stress and inflammation markers.
Reishi ExtractPeer-reviewed study
Antioxidant properties of Ganoderma lucidum extracts: a review
- Population
- In vitro and animal models
- Studied dose
- Not applicable
- Duration
- Not applicable
In vitro and animal studies demonstrate antioxidant activity via free radical scavenging and increased antioxidant enzyme activity.
Reishi ExtractPeer-reviewed study
Effects of Ganoderma lucidum on immune function in healthy adults: a randomized, double-blind, placebo-controlled trial
- Population
- Healthy adults (n=60)
- Studied dose
- 500 mg/day
- Duration
- 4 weeks
Reishi extract (500 mg, standardized to polysaccharides) improved immune parameters (NK cell activity, lymphocyte count) vs placebo in 60 healthy adults over 4 weeks.
Reishi ExtractPeer-reviewed study
Ganoderic acids from Ganoderma lucidum: anti-inflammatory and immunomodulatory effects
- Population
- In vitro (macrophage cell lines)
- Studied dose
- Not applicable
- Duration
- Not applicable
In vitro study showing ganoderic acids inhibit NF-κB and reduce pro-inflammatory cytokines in macrophages.
Reishi ExtractPeer-reviewed study
Ganoderma lucidum (Reishi) for sleep and stress: a systematic review
- Population
- Adults with sleep complaints or stress
- Studied dose
- 500-1500 mg/day
- Duration
- 4-12 weeks
Systematic review of 5 RCTs found some evidence for improved sleep quality and reduced fatigue, but studies were heterogeneous and small.
The formulas above sit in this private-label range:
Adjacent actives
Ingredients that sit alongside this one
Start Build a formula around Reishi Extract
Explore the private-label options that use Reishi Extract — review formula, format and packaging on each product before you commit.
